Pharmaceutical company advances that \"the test is done with a simple device that detects the presence of a substance in a liquid sample without the need for specialized and expensive equipment.\" <\/p>\n\n\n
The pharmaceutical company BioJam notified the National Authority of Medicines and Health Products (Infarmed) for the distribution of NADAL COVID-19 Ag rapid antigen tests. This is a test that \"allows detecting, from the first 24 hours of contagion, a virus protein that allows determining the infection,\" having a \"detection window similar to PCR tests.\" Results are obtained in 15 minutes.<\/p>\n\n\n
In these rapid antigen tests presented by BioJam, there is also no need for instrumentation, \"which significantly reduces false positives generated by contamination from other tests,\" the company states in a press release.<\/p>\n\n\n
According to the pharmaceutical company, rapid tests are \"reliable and accessible,\" enabling the detection of \"infection outbreaks on a large scale\" and \"thus reducing the spread of the disease.\"<\/p>\n\n\n
BioJam. Rapid antigen test allows detection of Covid-19 in 15 minutes.<\/p>\n\n\n
\"This is a diagnostic tool that, based on a lateral flow system, does not require instrumentation, that is, the test is done with a simple device that detects the presence of a substance in a liquid sample without the need for specialized and expensive equipment,\" it is added.<\/p>\n\n\n
BioJam. Rapid antigen test allows detection of Covid-19 in 15 minutes.<\/p>\n\n\n
BioJam also provides healthcare professionals to conduct tests in companies themselves to ensure \"a quick response in controlling possible infection cases.\" <\/p>\n\n\n
<\/p>\n\n\n